Evidence map›Paper›PMID 39045323›Full record

SynthesisFrontiers in genetics2024

The association of metabolic syndrome with telomere length as a marker of cellular aging: a systematic review and meta-analysis.

Sulieman Ibraheem Shelash Al-Hawary, Abdullah Ali Alzahrani, Hatem Ghaleb Maabreh, Mohammed Abed Jawad, Salim B Alsaadi, Noura Kareem Jabber, Ahmed Alawadi, Ali Alsalamy, Farideh Alizadeh

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sulieman Ibraheem Shelash Al-HawaryDepartment of Business Administration, Business School, Al al-Bayt University, Mafraq, Jordan.
Abdullah Ali AlzahraniDepartment of Surgery, Taif University, Taif, Saudi Arabia.
Hatem Ghaleb MaabrehDepartment of Dermatovenerology, Foreign Languages, Patrice Lumumba Peoples' Friendship University of Russia (RUDN University), Moscow, Russia.
Mohammed Abed JawadDepartment of Pharmaceutics, Al-Nisour University College, Baghdad, Iraq.
Salim B AlsaadiDepartment of Pharmaceutics, Al-Hadi University College, Baghdad, Iraq.
Noura Kareem JabberCollege of Health and Medical Technology, Al-Ayen University, Nasiriyah, Iraq.
Ahmed AlawadiCollege of Technical Engineering, The Islamic University, Najaf, Iraq.
Ali AlsalamyCollege of Technical Engineering, Imam Ja'afar Al-Sadiq University, Samawah, Iraq.
Farideh AlizadehDepartment of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It has been suggested that metabolic syndrome (MetS) accelerates the aging process, potentially contributing to the development of age-related complications. Available studies examining the relation of MetS to telomere length (TL), a putative biological marker of aging, have yielded inconclusive findings. This meta-analysis was performed to investigate the association between MetS and TL. Methods: A comprehensive systematic search was conducted in PubMed and Scopus databases to identify relevant literature published up to February 2024. Standard mean difference (SMD) and standardized beta coefficient (β) with their 95% confidence intervals (CI) were used as effect sizes to measure the associations using the random effects model. Results: A total of nine studies, comprising a total sample size of 8,606 participants, were eligible for the meta-analysis. No significant difference in mean TL was found between patients with and without MetS (SMD = -0.03, 95%CI = -0.17 to 0.10), with a significant heterogeneity across the studies ( Conclusion: This meta-analysis highlighted that MetS may be linked to a shorter TL. Additional studies are required to confirm this finding.

Indexed as

agingmeta-analysismetabolic syndrometelomerasetelomere length

Identifiers

PMID39045323
PMCPMC11263212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.